Skip to main content

Table 4 Expected reductions in LDL-C with atorvastatin 10 mg and the four most common treatment regimens from the questionnaire[31],[45]-[49]

From: Patient and physician factors influence decision-making in hypercholesterolemia: a questionnaire-based survey

Treatment

Expected LDL-C reduction (%)*

Estimated additional LDL-C reduction for patients on ATV 10 mg (%)

ATV 10 mg

38

-

ATV 20 mg

44

10

EZE 10 mg + ATV 10 mg

53

24

EZE + ATV 20 mg

54

26

RSV 10 mg

49

18

  1. *Treatment-naïve patients.
  2. ATV, atorvastatin; EZE, ezetimibe; LDL-C, low-density lipoprotein cholesterol; RSV, rosuvastatin.
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X